Skip to main content

JPMORGAN CHASE & CO

Position in PRME — Prime Medicine, Inc.

CIK 19617 NEW YORK, NY

Position in PRME

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,989,248
+$51,595 QoQ
Shares Held
810,095
-4.0% QoQ
Ownership
0.447%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 186 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. PRME ranks #130 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,989,248 810,095
2026-03-31 $2,937,653 844,154
2025-12-31 $1,511,912 435,710
2025-09-30 $240,374 43,389
2025-06-30 $81,595 33,035
2025-03-31 $70,968 35,663
2024-12-31 $104,067 35,640
2024-09-30 $144,667 37,382
2024-06-30 $196,279 38,187
2024-03-31 $294,567 42,081
2023-12-31 $403,297 45,519
2023-09-30 $257,713 27,014
2023-06-30 $449,344 30,672
2023-03-31 $158,633 12,897
2022-12-31 $183,458 9,874